Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

6.11
BATS BZX Real-Time Price
As of 12:32pm ET
 +0.05 / +0.83%
Today’s Change
5.06
Today|||52-Week Range
11.74
-12.71%
Year-to-Date

Today’s Trading

Previous close6.06
Today’s open6.14
Day’s range6.01 - 6.17
Volume80,894
Average volume (3 months)697,080
Market cap$119.6M
Dividend yield--
Data as of 12:16pm ET, 05/06/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-8.53%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
PTBIPlasmaTech Biopharma...+4.05+67.84%
LPCNLipocine Inc-0.14-2.01%
ADHDAlcobra Ltd0.000.00%
CPIXCumberland Pharmaceu...-0.10-1.45%
Data as of 12:32pm ET, 05/06/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers